|
1
|
Castermans K and Griffioen AW: Tumor blood vessels, a difficult hurdle for infiltrating leukocytes. Biochim Biophys Acta. 1776:160–174. 2007.PubMed/NCBI
|
|
2
|
Wettschureck N, Strilic B and Offermanns S: Passing the vascular barrier: Endothelial signaling processes controlling extravasation. Physiol Rev. 99:1467–1525. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Herberman RB, Nunn ME, Holden HT and Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer. 16:230–139. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shrikant P and Mescher MF: Control of syngeneic tumor growth by activation of CD8+ T cells: Efficacy is limited by migration away from the site and induction of nonresponsiveness. J Immunol. 162:2858–2866. 1999.PubMed/NCBI
|
|
5
|
Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ and Schreiber RD: Adaptive immunity maintains occult cancer in an equilibrium state. Nature. 450:903–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu NZ, Klitzman B, Dodge R and Dewhirst MW: Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res. 52:4265–4268. 1992.PubMed/NCBI
|
|
7
|
Kuzu I, Bicknell R, Fletcher CD and Gatter KC: Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest. 69:322–328. 1993.PubMed/NCBI
|
|
8
|
Piali L, Fichtel A, Terpe HJ, Imhof BA and Gisler RH: Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J Exp Med. 181:811–816. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Griffioen AW, Damen CA, Martinotti S, Blijham GH and Groenewegen G: Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: The role of angiogenic factors. Cancer Res. 56:1111–1117. 1996.PubMed/NCBI
|
|
10
|
Dirkx AE, Oude Egbrink MG, Kuijpers MJ, van der Niet ST, Heijnen VV, Bouma-ter Steege JC, Wagstaff J and Griffioen AW: Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res. 63:2322–2329. 2003.PubMed/NCBI
|
|
11
|
Soncin F, Mattot V, Lionneton F, Spruyt N, Lepretre F, Begue A and Stehelin D: VE-statin, an endothelial repressor of smooth muscle cell migration. EMBO J. 22:5700–5711. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Parker LH, Schmidt M, Jin SW, Gray AM, Beis D, Pham T, Frantz G, Palmieri S, Hillan K, Stainier DY, et al: The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature. 428:754–758. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fitch MJ, Campagnolo L, Kuhnert F and Stuhlmann H: Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells. Dev Dyn. 230:316–324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pinte S, Caetano B, Le Bras A, Havet C, Villain G, Dernayka R, Duez C, Mattot V and Soncin F: Endothelial cell activation is regulated by epidermal growth factor-like domain 7 (Egfl7) during inflammation. J Biol Chem. 291:24017–24028. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Díaz R, Silva J, García JM, Lorenzo Y, García V, Peña C, Rodríguez R, Muñoz C, García F, Bonilla F and Domínguez G: Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer. 47:794–802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu F, Yang LY, Li YF, Ou DP, Chen DP and Fan C: Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology. 50:1839–1850. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang CH, Li XJ, Zhou YZ, Luo Y, Li C and Yuan XR: Expression and clinical significance of EGFL7 in malignant glioma. J Cancer Res Clin Oncol. 136:1737–1743. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou L, Li J, Zhao YP, Guo JC, Cui QC, Zhou WX, Zhang TP, Wu WM, You L and Shu H: Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer. Hepatobiliary Pancreat Dis Int. 13:523–528. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Delfortrie S, Pinte S, Mattot V, Samson C, Villain G, Caetano B, Lauridant-Philippin G, Baranzelli MC, Bonneterre J, Trottein F, et al: Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation. Cancer Res. 71:7176–7186. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pannier D, Philippin-Lauridant G, Baranzelli MC, Bertin D, Bogart E, Delprat V, Villain G, Mattot V, Bonneterre J and Soncin F: High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer. Oncol Lett. 12:1422–1428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Doliana R, Bot S, Bonaldo P and Colombatti A: EMI, a novel cysteine-rich domain of EMILINs and other extracellular proteins, interacts with the gC1q domains and participates in multimerization. FEBS Lett. 484:164–168. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Callebaut I, Mignotte V, Souchet M and Mornon JP: EMI domains are widespread and reveal the probable orthologs of the caenorhabditis elegans CED-1 protein. Biochem Biophys Res Commun. 300:619–623. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Campbell ID and Bork P: Epidermal growth factor-like modules. Curr Opin Struct Biol. 3:385–392. 1993. View Article : Google Scholar
|
|
24
|
Schmidt MHH, Bicker F, Nikolic I, Meister J, Babuke T, Picuric S, Müller-Esterl W, Plate KH and Dikic I: Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal. Nat Cell Biol. 11:873–880. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abramoff MD, Magalhães P and Ram SJ: Image processing with imageJ. Biophot Int. 11:36–42. 2004.
|
|
26
|
Tomayko MM and Reynolds CP: Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol. 24:148–154. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chiu JJ: Shear stress increases ICAM-1 and decreases VCAM-1 and E-selectin expressions induced by tumor necrosis factor-[alpha] in endothelial cells. Arterioscler Thromb Vasc Biol. 24:73–79. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Durrans A and Stuhlmann H: A role for Egfl7 during endothelial organization in the embryoid body model system. J Angiogenes Res. 2:42010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nichol D, Shawber C, Fitch MJ, Bambino K, Sharma A, Kitajewski J and Stuhlmann H: Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7. Blood. 116:6133–6143. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
D'Audigier C, Susen S, Blandinieres A, Mattot V, Saubamea B, Rossi E, Nevo N, Lecourt S, Guerin CL, Dizier B, et al: Egfl7 represses the vasculogenic potential of human endothelial progenitor cells. Stem Cell Rev Rep. 14:82–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Taddei ML, Giannoni E, Fiaschi T and Chiarugi P: Anoikis: An emerging hallmark in health and diseases. J Pathol. 226:380–393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Philippin-Lauridant G, Baranzelli MC, Samson C, Fournier C, Pinte S, Mattot V, Bonneterre J and Soncin F: Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer. Int J Oncol. 42:1367–1375. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fehon RG, Kooh PJ, Rebay I, Regan CL, Xu T, Muskavitch MA and Artavanis-Tsakonas S: Molecular interactions between the protein products of the neurogenic loci Notch and delta, two EGF-homologous genes in Drosophila. Cell. 61:523–534. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rebay I, Fleming RJ, Fehon RG, Cherbas L, Cherbas P and Artavanis-Tsakonas S: Specific EGF repeats of Notch mediate interactions with delta and serrate: Implications for Notch as a multifunctional receptor. Cell. 67:687–699. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Downing AK, Knott V, Werner JM, Cardy CM, Campbell ID and Handford PA: Solution structure of a pair of calcium-binding epidermal growth factor-like domains: Implications for the Marfan syndrome and other genetic disorders. Cell. 85:597–605. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ranganathan P, Weaver KL and Capobianco AJ: Notch signalling in solid tumours: A little bit of everything but not all the time. Nat Rev Cancer. 11:338–351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hayakawa S, Koide R, Hinou H and Nishimura SI: Synthetic human NOTCH1 EGF modules unraveled molecular mechanisms for the structural and functional roles of calcium ions and O-glycans in the ligand-binding region. Biochemistry. 55:776–787. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Taylor P, Takeuchi H, Sheppard D, Chillakuri C, Lea SM, Haltiwanger RS and Handford PA: Fringe-mediated extension of O-linked fucose in the ligand-binding region of Notch1 increases binding to mammalian Notch ligands. Proc Natl Acad Sci USA. 111:7290–7295. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hidai C, Zupancic T, Penta K, Mikhail A, Kawana M, Quertermous EE, Aoka Y, Fukagawa M, Matsui Y, Platika D, et al: Cloning and characterization of developmental endothelial locus-1: An embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Genes Dev. 12:21–33. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhong J, Eliceiri B, Stupack D, Penta K, Sakamoto G, Quertermous T, Coleman M, Boudreau N and Varner JA: Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. J Clin Invest. 112:30–41. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Aoka Y, Johnson FL, Penta K, Hirata Ki K, Hidai C, Schatzman R, Varner JA and Quertermous T: The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formation. Microvasc Res. 64:148–161. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M, Kundu RK, Orlandi A, Zheng YY, Prieto DA, et al: Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science. 322:1101–1104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Choi EY: Inhibition of leukocyte adhesion by developmental endothelial locus-1 (del-1). Immune Netw. 9:153–157. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Villain G, Lelievre E, Broekelmann T, Gayet O, Havet C, Werkmeister E, Mecham R, Dusetti N, Soncin F and Mattot V: MAGP-1 and fibronectin control EGFL7 functions by driving its deposition into distinct endothelial extracellular matrix locations. FEBS J. 285:4394–4412. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Verginelli F, Adesso L, Limon I, Alisi A, Gueguen M, Panera N, Giorda E, Raimondi L, Ciarapica R, Campese AF, et al: Activation of an endothelial Notch1-Jagged1 circuit induces VCAM1 expression, an effect amplified by interleukin-1β. Oncotarget. 6:43216–43229. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nus M, Martínez-Poveda B, MacGrogan D, Chevre R, D'Amato G, Sbroggio M, Rodríguez C, Martínez-González J, Andrés V, Hidalgo A and de la Pompa JL: Endothelial Jag1-RBPJ signalling promotes inflammatory leucocyte recruitment and atherosclerosis. Cardiovasc Res. 112:568–580. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Quillard T, Coupel S, Coulon F, Fitau J, Chatelais M, Cuturi MC, Chiffoleau E and Charreau B: Impaired Notch4 activity elicits endothelial cell activation and apoptosis: Implication for transplant arteriosclerosis. Arterioscler Thromb Vasc Biol. 28:2258–2265. 2008. View Article : Google Scholar : PubMed/NCBI
|
